| Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment CJG Garcia, Y Huang, NR Fuentes, MC Turner, ME Monberg, D Lin, ... Gastroenterology 162 (7), 2018-2031, 2022 | 80 | 2022 |
| Independent reproduction of the FLASH effect on the gastrointestinal tract: a multi-institutional comparative study A Valdés Zayas, N Kumari, K Liu, D Neill, A Delahoussaye, ... Cancers 15 (7), 2121, 2023 | 11 | 2023 |
| Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model AM Delahoussaye, J Abi Jaoude, M Green, TN Fujimoto, J Molkentine, ... BMC cancer 22 (1), 174, 2022 | 3 | 2022 |
| Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells W Guo, J Hoque, CJ Garcia Garcia, KV Spiller, AP Leinroth, V Puviindran, ... Science translational medicine 15 (724), eabo5217, 2023 | 1 | 2023 |
| Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment Y Huang, CJ Garcia Garcia, D Lin, ND Nguyen, TN Fujimoto, J Zhao, ... bioRxiv, 2021.05. 21.445190, 2021 | 1 | 2021 |
| Redefining FLASH RT: the impact of mean dose rate and dose per pulse in the gastrointestinal tract K Liu, T Waldrop, E Aguilar, N Mims, D Neill, A Delahoussaye, Z Li, ... bioRxiv, 2024.04. 19.590158, 2024 | | 2024 |
| Hypo-Fractionated Ultra-High Dose Rate (FLASH) Radiation Therapy Reduces Leg Contracture in Mouse Model NA West, L Connell, K Liu, BD Velasquez, E Wang, N Mims, E Aguilar, ... AAPM 65th Annual Meeting & Exhibition, 2023 | | 2023 |
| Producing genetically defined CAFs for the study of hypoxia signaling in the pancreatic cancer TME SB Fattani, MT Cribb, AM Delahoussaye, NP Mims, NR Fuentes, ... Cancer Research 83 (7_Supplement), 2347-2347, 2023 | | 2023 |
| Pharmacological Inhibition of HIF-2 alpha Signaling in LepR-expressing Skeletal Stem Cells Ameliorates Radiation-induced Bone Loss W Guo, K Spiller, C Garcia, T Fujimoto, D Johnson, A Delahoussaye, ... JOURNAL OF BONE AND MINERAL RESEARCH 37, 342-342, 2022 | | 2022 |
| Mitochondrial fusion exerts KRAS-dependent therapeutic synergy with gemcitabine/nab-paclitaxel in preclinical models of pancreatic cancer ND Nguyen, M Yu, TN Fujimoto, A Delahoussaye, Y Huang, MA Estrada, ... Cancer Research 80 (16_Supplement), 555-555, 2020 | | 2020 |
